Showing results (21-30 of 46) with videos related to
Sort By:
Pageof 5
Annals of Hematology|November 29, 2023
Young patients with myelofibrosis have distinct clinicomolecular features, favorable prognosis, and commonly exhibit inflammatory comorbiditiesNathan P Horvat, Enas F Abdallah, Zhuoer Xie, et al.Cancer Medicine|December 22, 2020
Validation of International Working Group response criteria in higher-risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research ConsortiumRami S Komrokji, Najla H Al Ali, David Sallman, et al.Clinical Lymphoma, Myeloma & Leukemia|March 28, 2024
Triple-Negative Myelofibrosis: Disease Features, Response to Treatment and OutcomesLuis E Aguirre, Akriti Jain, Somedeb Ball, et al.Clinical Lymphoma, Myeloma & Leukemia|February 5, 2019
A Phase II Study to Determine the Safety and Efficacy of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase (IDO) Enzyme INCB024360 in Patients with Myelodysplastic SyndromesRami S Komrokji, Sheng Wei, Adam W Mailloux, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2022
Eprenetapopt Plus Azacitidine After Allogeneic Hematopoietic Stem-Cell Transplantation for TP53-Mutant Acute Myeloid Leukemia and Myelodysplastic SyndromesAsmita Mishra, Roni Tamari, Amy E DeZern, et al.Leukemia Research|May 15, 2020
Comparison of induction strategies and responses for acute myeloid leukemia patients after resistance to hypomethylating agents for antecedent myeloid malignancyChetasi Talati, Aaron D Goldberg, Amanda Przespolewski, et al.Transplantation and Cellular Therapy|August 15, 2024
Melphalan Dose in Combination With Fludarabine Affects Gastrointestinal Toxicity and Graft-Versus-Host Disease After Allogeneic Transplantation in Acute Myeloid Leukemia and Myelodysplastic SyndromesOmar Albanyan, Hany Elmariah, Denise Kalos, et al.Blood Cancer Journal|February 2, 2022
Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patientsAbhishek A Mangaonkar, Terra L Lasho, Rhett P Ketterling, et al.Clinical Lymphoma, Myeloma & Leukemia|January 9, 2023
Clinical Response to Upfront Targeted Tyrosine Kinase Inhibitors among Patients with Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene FusionYumeng Zhang, Lynn Nguyen, Chuanyi M Lu, et al.Annals of Hematology|July 2, 2026
Impact of race on mutational profile and survival in acute myeloid leukemia: a single-institution experience (2014-2024)Utsav Joshi, Fatima Tuz Zahra, Pujan Patel, et al.Pageof 5